136 related articles for article (PubMed ID: 12854903)
1. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
2. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
3. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
5. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
6. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells.
Feldhahn N; Río P; Soh BN; Liedtke S; Sprangers M; Klein F; Wernet P; Jumaa H; Hofmann WK; Hanenberg H; Rowley JD; Müschen M
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13266-71. PubMed ID: 16141323
[TBL] [Abstract][Full Text] [Related]
8. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.
Kersseboom R; Ta VB; Zijlstra AJ; Middendorp S; Jumaa H; van Loo PF; Hendriks RW
J Immunol; 2006 Apr; 176(8):4543-52. PubMed ID: 16585544
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites.
Himmelmann A; Thevenin C; Harrison K; Kehrl JH
Blood; 1996 Feb; 87(3):1036-44. PubMed ID: 8562928
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase.
Mesci L; Ozdag H; Turul T; Ersoy F; Tezcan I; Sanal O
Turk J Pediatr; 2006; 48(4):362-4. PubMed ID: 17290574
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients.
De Weers M; Dingjan GM; Brouns GS; Kraakman ME; Mensink RG; Lovering RC; Schuurman RK; Borst J; Hendriks RW
Clin Exp Immunol; 1997 Feb; 107(2):235-40. PubMed ID: 9030858
[TBL] [Abstract][Full Text] [Related]
13. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous t(4;11) fusion transcripts in two infants with acute lymphoblastic leukemia.
Gill HK; Ten SK; Dhaliwal JS; Moore S; Hassan R; Karim FA; Zakaria Z; Murad S; Mohamed M; Ibrahim HM; Rahman EJ
Malays J Pathol; 2004 Dec; 26(2):105-10. PubMed ID: 16329562
[TBL] [Abstract][Full Text] [Related]
15. Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia.
Wood CM; Goodman PA; Uckun FM
Leuk Lymphoma; 2002 Dec; 43(12):2355-62. PubMed ID: 12613524
[TBL] [Abstract][Full Text] [Related]
16. Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.
Haire RN; Ohta Y; Strong SJ; Litman RT; Liu Y; Prchal JT; Cooper MD; Litman GW
Am J Hum Genet; 1997 Apr; 60(4):798-807. PubMed ID: 9106525
[TBL] [Abstract][Full Text] [Related]
17. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V; Seidenspinner S; Kreth HW
Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
[TBL] [Abstract][Full Text] [Related]
18. Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains.
Oeltjen JC; Malley TM; Muzny DM; Miller W; Gibbs RA; Belmont JW
Genome Res; 1997 Apr; 7(4):315-29. PubMed ID: 9110171
[TBL] [Abstract][Full Text] [Related]
19. Bruton's tyrosine kinase: potential target in human multiple myeloma.
Liu Y; Dong Y; Jiang QL; Zhang B; Hu AM
Leuk Lymphoma; 2014 Jan; 55(1):177-81. PubMed ID: 23581641
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
Uckun F; Ozer Z; Vassilev A
Br J Haematol; 2007 Feb; 136(4):574-89. PubMed ID: 17367410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
